Good post, thx TonyIndo.
In relation to Roche, the feedback I have received on Roche is "The Roche extension is on track to trigger a decision from Roche on whether to exercise their option to license by the end of 2011 (ie: a payment)."
Some clarity around Roche would be great as the opportunities here seem enormous, but they are certainly playing their cards close to their chest. Hopefully we'll see something in the next 4C, if not sooner.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.010(0.77%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.28 | $2.349M | 1.814M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 671 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10326 | 4 |
View Market Depth
| Last trade - 11.05am 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |